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We conducted a case-control study to identify risk fac-
tors for invasive group A streptococcal (GAS) infections,
which can be fatal. Case-patients were identified when
Streptococcus pyogenes was isolated from a normally ster-
ile site and control subjects (two or more) were identified
and matched to case-patients by using sequential-digit
telephone dialing. All participants were noninstitutionalized
surveillance area residents, >18 years of age. Conditional
logistic regression identified the risk factors for invasive
GAS infection: in adults 18 to 44 years of age, exposure to
one or more children with sore throats (relative risk
[RR]=4.93, p=0.02), HIV infection (RR =15.01, p=0.04),
and history of injecting drug use (RR=14.71, p=0.003); in
adults >45 years of age, number of persons in the home
(RR=2.68, p=0.004), diabetes (RR= 2.27, p=0.03), cardiac
disease (RR=3.24, p=0.006), cancer (RR= 3.54, p=0.006),
and corticosteroid use (RR=5.18, p=0.03). Thus, host and
environmental factors increased the risk for invasive GAS
disease.  
I
nvasive GAS infection can lead to dramatic, rapidly-pro-
gressive syndromes such as necrotizing fasciitis and
streptococcal toxic shock syndrome (STSS). An estimated
9,500 cases of invasive GAS disease occurred in the
United States in 1999, resulting in approximately 1,100
deaths. The overall case-fatality rate of invasive GAS is
estimated to be from 10% to 15%, and the case-fatality rate
for STSS can exceed 60% (1). Most of these infections are
community-acquired. 
Although case series and population-based surveillance
have identified several possible host risk factors for the
development of invasive GAS disease, including age,
Native American ethnicity, HIV infection, diabetes melli-
tus, cardiovascular disease, alcoholism, and other chronic
diseases (1–3), these studies have not been able to assess
household risk factors. In addition, surveillance studies
identified possible risk factors by comparing prevalence of
host factors among GAS patients (by using medical record
data) to prevalence of host factors among the general pop-
ulation using population-based estimates (1,2). These com-
parisons are limited by the completeness and availability
of both kinds of data.  
Household-based studies conducted in the 1950s
demonstrated that school-aged children were most often
responsible for introducing a GAS strain into a household
and that mothers were more likely to subsequently acquire
the bacteria than fathers (4). These studies suggest that
exposure to children and duration of exposure to a GAS-
infected person influence the transmission of GAS within
households. However, community studies have not shown
the relative importance of these factors compared to host
factors. 
We conducted a case-control study to evaluate the
importance of previously identified risk factors for inva-
sive GAS infection: contact with other persons in the
home, with children, with persons symptomatic with GAS
disease in the home, with other persons at work, and with
persons symptomatic with GAS disease at work.
Methods
Invasive GAS disease was defined as the isolation of
Streptococcus pyogenes from a normally sterile site (e.g.,
blood, cerebrospinal fluid, pleural fluid, peritoneal fluid,
pericardial fluid, joint fluid, surgical specimens, bone, and
scrotal fluid) in a noninstitutionalized resident, >18 years
of age, in a surveillance area. Persons who had group A
Streptococcus isolated from a sterile site more than 48
hours after hospital admission were presumed to have a
nosocomial infection (5) and were excluded. 
Cases of invasive GAS disease were identified through
active, laboratory-based surveillance in three areas: metro-
politan Atlanta, Georgia, from July 1, 1997, through June
30, 1999; metropolitan Baltimore, Maryland, from July 1,
1997, through June 30, 1999, and the Toronto-Peel region,
Ontario, Canada, from July 1, 1997, through December 31,
1997. The surveillance area population was estimated to
include 9 million people (3,627,184 in metropolitan
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3,008,570 in the Toronto-Peel region based on 1997
Bureau of Census estimates [6]). All acute-care hospitals
and laboratories serving the residents of the surveillance
area were contacted biweekly and audited semiannually to
identify patients with invasive GAS disease. 
A“case algorithm” was used to contact persons infect-
ed with invasive GAS infection. For each case-patient
identified, up to 15 separate telephone calls were made to
contact the patient. To maximize the likelihood of con-
tacting the case-patient, the telephone calls were made on
5 nonconsecutive days, including at least 1 weekend day,
during each of three different time periods (8 a.m.–noon;
noon–5 p.m.; 5 p.m.–8 p.m.). The party was considered
unavailable for that call if the telephone was allowed to
ring 10 times or if an answering machine picked up the
phone. Persons still hospitalized when the case was iden-
tified were interviewed by phone in the hospital when
feasible. Case-patients were eligible if their enrollment
was complete within 3-months of onset of their GAS dis-
ease. 
To both maximize enrollment and limit bias, several
arrangements were made. Family members of deceased
case-patients were interviewed. Non–English-speaking
patients were included if the individual surveillance sites
had the resources to communicate with the patients in their
language. 
Apopulation-based sample of matched control subjects
was selected through a process of systematic, sequential-
digit telephone dialing. Case-patients and control subjects
were matched by age group, postal or zip code, and tele-
phone exchange. Age groups were defined as follows:
18–44 years of age, 45–64 years of age, and >65 years of
age. Matching was done on postal or zip code and tele-
phone exchange to control for socioeconomic status.
Because control-subjects were identified by telephone
interview, case-patients who did not have a telephone were
excluded.
A“control algorithm” was used to identify control sub-
jects. Control identification began after a case-patient had
been identified, confirmed as eligible, and enrolled in the
study. Phone numbers for control subjects were generated
by incrementally adjusting the enrolled case-patient’s
home phone number. For example, if an enrolled case-
patient’s telephone number ended in 1234, the first phone
number used to identify a control had the same area code
and exchange and ended in 1235. The numbers generated
for control subjects were called a maximum of four times
over several days. Any number of phone numbers were
called at one time. Calling continued until 1) a minimum
of two control subjects were enrolled per case-patient, and
2) all numbers that had been called at least once complet-
ed the control algorithm. As a result, more than two con-
trol subjects were enrolled for some case-patients. The
purpose of completing the control algorithm was to ensure
that the control group was not biased towards households
that were easier to contact. 
When experienced surveillance personnel reached the
case-patient or control subject, they explained the purpose
of the study, obtained informed consent, and administered
a standardized questionnaire. This study was approved by
the Institutional Review Boards at the Centers for Disease
Control and Prevention and at each of the sponsoring insti-
tutions.
Questionnaire
The questionnaire included demographic information,
socioeconomic status, smoking status of the interviewee,
smoking status of other persons in the home, medical his-
tory, and history of alcohol and injecting drug use. Within
the medical history section, we differentiated between
“regular” nonsteroidal antiinflammatory drug (NSAID)
use and “new” NSAID use. New NSAID use implied that
the case-patient had started using NSAIDs in the 2 weeks
before their illness or that a control subject had started
using NSAIDs in the 2 weeks before their interview. Each
case-patient and control subject were allowed to self-
define “regular use” of NSAIDS. To screen for alcoholism,
we used the CAGE questionnaire in which a subject is
asked four questions about his or her relationship to alco-
hol. The likelihood of alcoholism increases with the num-
ber of times the person answers “Yes” (7). 
The questionnaire also asked about contact with other
persons in the home, contact with children, contact with
persons exhibiting symptoms of GAS disease in the home,
contact with other persons at work, and contact with per-
sons with symptoms of GAS disease at work. To evaluate
contact with other persons in the home, the questionnaire
included questions about number of persons in the home,
crowding in the home (number of persons per room), type
of home, age of all persons living in the home, and types
of relationships with all persons living in the home. To
evaluate contact with children, the questionnaire asked
about the number of children in the home (i.e., persons <18
years of age), amount of time spent with children in the
home, frequency of certain types of sharing behavior with
children in the home (including eating off the same plate,
sharing a beverage, sleeping in the same bed), amount of
time spent with children who did not live in the home, and
frequency of sharing behavior with children who did not
live in the home.
The questionnaire asked whether anyone in the home
had been ill in the 2 weeks before the case-patient’s illness
or the control subject’s interview by asking about specific
types of illnesses. For example, the questionnaire asked
“Has anyone in your household, other than yourself, had a
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asked how many children and how many adults had a sore
throat during that period. The questions asked whether
anyone in the home had a sore throat; fever; new cough;
new runny nose; skin infection; a diagnosis of strep throat,
an ear infection, or a sinus infection; or died. To measure
the severity of the illness, the questionnaire asked whether
the ill person(s) had visited a doctor, missed school or
work, had taken antibiotics, or had been hospitalized.
To evaluate exposure to both persons at work and
symptomatic persons at work, the questionnaire asked
which type of environment the case-patient or control sub-
ject worked in, how many hours she or he worked, how
many persons were in their work environment, and
whether anyone at work had been ill in the 2 weeks before
the case-patient’s illness or control subject interview by
asking about specific types of illnesses. The questions
were asked in the same manner as those asked of persons
in the home.
Statistical Analysis
Odds ratios (ORs) for each potential risk factor were
determined by using conditional logistic regression (Proc
PHREG, SAS Version 6.12, Cary, NC), controlling for sex
and race. These ORs were determined separately for age
groups 18–44 years of age and >45 years of age to identi-
fy age-dependent risk factors. Those variables found to
have a p value >0.20 in individual analyses were included
in multivariable analysis. Computer-assisted and manual
forward, backward, and stepwise conditional logistic
regression was done to identify risk factors independently
associated with invasive GAS disease. ORs with 95% con-
fidence intervals (CIs) that do not include 1.00, and p val-
ues <0.05 were considered statistically significant in mul-
tivariable analysis. 
Results
Surveillance identified 401 episodes of invasive GAS
disease among adults >18 years of age; 390 persons were
traceable and were screened by surveillance personnel for
possible participation. Of the 390 persons with invasive
GAS disease, 49 were ineligible (36 due to nosocomial
infection and 13 due to institutionalization). Of the remain-
ing 341 case-patients, 139 were enrolled, 24 refused to par-
ticipate, 27 were not reached after exhausting the tele-
phone case algorithm, and the rest were nonparticipants.
Reasons for nonparticipation included the following:
refusal to allow participation by spouse or surrogate, >3
months had elapsed since the illness, incomplete or incor-
rect contact information (i.e., wrong phone number, dis-
connected phone, no phone, homelessness), and difficulty
with communication over the phone (i.e., poor communi-
cation skills, non–English-speaking patient). 
The number of case-patients and control subjects
enrolled varied by area: 58 case-patients were from
Atlanta, 49 case-patients were from Baltimore, and 32
case-patients were from Toronto. Of the 139 case-patients
enrolled, 48 (34%) were 18–44 years of age, 54 (39%)
were 45–64 years of age, and 37 (27%) were >65 years of
age. Of the 139 case-patients, 70 (50%) were men, 75
(54%) were white, and 60 (43%) were African-American
(Table 1). Eighteen (13%) of 139 patients died. Primary
bacteremia and cellulitis were the two most common diag-
noses (Table 2). The organism was most commonly identi-
fied from blood.
Several factors were associated with invasive GAS dis-
ease among those 18–44 years of age (Table 3). When sex
and race were controlled for, HIV seropositivity and histo-
ry of injecting drug use were significantly associated with
invasive GAS disease (p<0.05) when each variable was
analyzed individually. Smoking, presence of children in
the home, diabetes, cancer, regular use of NSAIDs, corti-
costeroid use, and alcohol abuse were not associated with
invasive GAS disease. Using multivariable conditional
logistic regression and controlling for sex and race, we
found that three risk factors were independently associated
with invasive GAS disease: having one or more children
with a sore throat in the home in the past 2 weeks
(RR=4.93, p=0.02), HIV seropositivity (RR=15.01,
p=0.04), and history of injecting drug use (RR=14.71,
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Table 1. Characteristics of patients with invasive group A 
streptococcal disease, Atlanta, Baltimore, Toronto, 1997–1999 
Characteristic  Patients, N=139 (%) 
Geographic area   
Atlanta    58 (42) 
Baltimore  49 (35) 
Toronto  32 (23) 
Age group   
18–44  48 (34) 
45–64  54 (39) 
65+  37 (27) 
Sex   
Male  70 (50) 
Female   69 (50) 
Race   
White  75 (54) 
Black  60 (43) 
American Indian or Alaskan Native  1 (1) 
Asian or Pacific Islander  2 (1) 
Other or not specified  1 (1) 
Ethnicity   
Hispanic  2 (1) 
Non-Hispanic  137 (99) 
Outcome   
Lived  120 (86) 
Died  18 (13) 
Unknown  1 (1) p=0.003). Among those 18–44 years of age, one case-
patient had a history of paralysis, and no one had recent
varicella infection.  
Many factors were associated with invasive GAS dis-
ease in adults >45 years of age (Table 4). When the results
were controlled for sex and race, we found that the follow-
ing factors were significantly associated with invasive
GAS disease (p≤0.05): three or more persons living in the
home, any child living in the home, other smokers living in
the home, diabetes mellitus, cardiac disease, chronic
obstructive pulmonary disease (COPD), cancer, paralysis,
regular use of NSAIDs, use of corticosteroids, and history
of injecting drug use. Current smoking and alcohol abuse
were not associated with invasive GAS disease. When
multivariable conditional logistic regression analysis, con-
trolling for sex and race, was used, the following factors
were independently associated with GAS disease: three or
more persons living in the home (RR=2.68, p=0.004), dia-
betes mellitus (RR=2.27, p=0.03), cardiac disease
(RR=3.24, p=0.006), cancer (RR=3.54, p=0.006), and use
of corticosteroids (RR=5.18, p=0.03). 
Among adults >45 years of age, the only cases of cir-
rhosis and recent varicella infection occurred in case-
patients; five case-patients reported a history of cirrhosis,
and one case-patients reported a recent varicella infection.
Five (83%) of six persons with paralysis were in the case-
patient group. This difference was significant when this
variable was evaluated alone but did not reach statistical
significance in multivariable analysis. None of the six
patients with paralysis in this age group reported the pres-
ence of a decubitus ulcer; two of the persons with paraly-
sis indicated that they had open sores in other places.
Of the 47 patients who had a cutaneous focus of inva-
sive GAS infection (36 with cellulitis, 9 with necrotizing
fasciitis, and 2 with an abscess), 39 (83%) reported an
open sore, bruise, or burn before the onset of invasive GAS
symptoms, and 5 (11%) reported having been diagnosed
with a skin condition in the past (eczema, psoriasis, or seb-
orrheic dermatitis). 
Type of work environment, number of persons at work,
number of hours at work, and presence of an ill person at
work were not associated with invasive GAS infection in
either age group.
Discussion
This study suggests that both host and environmental
factors are associated with the risk of community-acquired
invasive GAS disease in adults. We found that the host fac-
tors of HIV infection, diabetes, malignancy, injecting drug
use, and cardiac disease were associated with an increased
risk of invasive GAS disease. The environmental factors
associated with an increased risk were household size and
the presence of a child with a sore throat. These environ-
mental factors highlight the importance of person-to-per-
son transmission of group A streptococcus.   
Although previous studies have found host risk factors
to be associated with invasive GAS infection, this study
found that the importance of host factors varied signifi-
cantly by patient’s age. In adults 18–44 years of age, HIV
infection and history of injecting drug use were associated
with invasive GAS disease. The association with HIV has
been previously identified (1) and suggests that immune
suppression increases the risk for invasive GAS disease.
The association with injecting drug use has been previous-
ly identified also (8) and may be because of the direct
injection of group A streptococci from the skin into the
blood. The increased risk associated with injecting drug
use was independent of that related to HIV infection.
Because control subjects identified by random digit dialing
may be reluctant to admit certain illicit behaviors and HIV
infection, our ascertainment of injecting drug use and HIV
infection among controls may be an underestimate; the
strong association between these two factors and invasive
GAS infection found in our study may be an overestimate
of the true value of this association. 
In older adults, diabetes mellitus, cardiac disease, cancer,
and corticosteroid use are associated with invasive GAS
infection. The association with diabetes, cancer, and corticos-
teroids again suggests that immune dysfunction is important
in the development of this disease. An association between
cardiac disease and invasive GAS infection was also sug-
gested in a recent 10-year population-based surveillance
study done in the San Francisco Bay area (8). The mecha-
nism by which cardiac disease increases the risk of inva-
sive GAS disease is not known but warrants further study.
Our data also suggest that paralysis, cirrhosis, and vari-
cella infections may be risk factors for invasive GAS dis-
Emerging Infectious Diseases • Vol. 9, No. 8, August 2003 973
RESEARCH
Table 2. Clinical syndromes of patients with invasive group A 
streptococcal disease, Atlanta, Baltimore, Toronto, 1997–1999 
Clinical syndromes
a  Patients, N=139 (%) 
Primary bacteremia (without focus)  57 (41) 
Cellulitis  36 (26) 
Septic arthritis    11 (8) 
Necrotizing fasciitis  9 (6) 
Pneumonia  8 (6) 
Streptococcal toxic shock syndrome  6 (4) 
Otitis  4 (3) 
Peritonitis  3 (2) 
Osteomyelitis  2 (2) 
Endometritis  2 (2) 
Abscess  2 (2) 
Puerperal sepsis  2 (2) 
Meningitis  1 (1) 
Endocarditis  1 (1) 
Urologic syndrome  1 (1) 
Other syndrome  18 (13) 
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Table 3. Individual risk factor and multivariable analysis for risk factors for invasive group A streptococcal disease among case-
patients and control subjects matched on age and zip code, 18–44 years of age, Atlanta, Baltimore, Toronto, 1997–1999
a,b,c 
  Individual risk factor analysis  Multivariable analysis 
Variable 
Case-patients 
(n=48) (%) 
Control subjects 
(n=115) (%)  OR (95% CI)  p value  OR (95% CI)  p value 
Number of persons living in the home 
3+ 
1–2 
38 (79) 
10 (21) 
80 (70) 
35 (30) 
1.91 (0.81 to 4.47)  0.14 
 
   
Smoke exposure 
Current smoker with 
passive smoke exposure 
6 (13)  17 (15)  1.04 (0.32 to 3.37)  0.95     
Current smoker without 
passive smoke exposure 
12 (25)  16 (14)  2.35 (0.85 to 6.48)  0.86     
Passive smoke exposure  6 (13)  12 (10)  1.82 (0.57 to 5.82)  0.31     
No smoke exposure  24 (50)  70 (61)  1.00       
Any child <18 years living in the home 
Yes 
No 
30 (63) 
18 (37) 
68 (59) 
47 (41) 
1.25 (0.59 to 2.64)  0.57 
 
   
>1 Child with sore  throat in the family 
Yes 
No 
7 (15) 
41 (85) 
7 (6) 
108 (94) 
2.75 (0.87 to 8.70)  0.09  4.93 (1.24 to 19.68)  0.02 
Diabetes mellitis 
Yes 
No 
6 (13) 
40 (87) 
5 (4) 
107 (96) 
2.11 (0.63 to 7.10)  0.23     
Cancer 
Yes 
No 
0 
47 (100) 
3 (3) 
108 (97) 
0  0.99     
Varicella 
Yes 
No 
0 
48 (100) 
0 
115 (100) 
       
Cirrhosis 
Yes 
No 
0 
48 (100) 
0 
115 (100) 
       
Paralysis 
Yes 
No 
1 (2) 
47 (98) 
0 
115 (100) 
Undefined       
Regular NSAID  use 
Yes 
No 
11 (26) 
32 (74) 
31 (28) 
78 (72) 
.97 (0.42 to 2.23)  0.93     
New use of NSAIDs 
Yes 
No 
9 (19) 
34 (81) 
10 (9) 
100 (91) 
2.15 (0.79 to 5.80)  0.13     
Use of corticosteroids 
Yes 
No 
0 
44 (100) 
3 (3) 
109 (97) 
0  0.99     
HIV+ 
Yes 
No 
7 (15) 
39 (85) 
1 (1) 
110 (99) 
12.66 (1.47 to 108.92)  0.02  15.01 (1.09 to 207.30)  .04 
Ever injected drugs 
Yes 
No 
10 (22) 
36 (78) 
3 (3) 
110 (97) 
11.80 (2.46 to 56.66)  0.002  14.71 (2.52 to 85.70)  .003 
Alcohol use (based on CAGE questions)
d 
CAGE score 0 
CAGE score 1 
CAGE score 2 
CAGE score 3 
CAGE score 4 
28 (72) 
5 (13) 
0 
5 (13) 
1 (3) 
57 (68) 
22 (26) 
3 (4) 
2 (2) 
0 
1.14 (0.69 to 1.89)  0.62     
aOR, odds ratio; CI, confidence interval; NSAID, nonsteroidal antiinflammatory drug. 
bDue to missing data, for some variables, data for fewer than 48 case-patients and 115 control subjects were available. 
cAnalyses controlled for race and sex. 
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Table 4. Individual risk factor and multivariable analysis for risk factors for invasive group A streptococcal disease case-patients and 
control subjects, matched by age group and zip code, 45+ years old, Atlanta, Baltimore, Toronto, 1997–1999
a,b,c 
  Individual risk factor analysis  Multivariable analysis 
Variable 
Case-patients 
(n=91) (%) 
Control subjects 
(n=196) (%)  OR (95% CI)  p value  OR (95% CI)  p value 
Number of persons living in the home 
3+ 
1–2 
47 (52) 
44 (48) 
55 (28) 
140 (72) 
2.64 (1.46 to 4.75)  0.001 
 
2.68 (1.37 to 5.28)  0.004 
Any child living in the home 
Yes 
No 
31 (34) 
60 (66) 
33 (17) 
163 (83)  2.12 (1.11 to 4.05)  0.02     
Smoke exposure  
Current smoker with passive smoke exposure 
  15 (16)  16 (8)  2.37 (0.94 to 6.01)  0.07     
Current smoker without passive smoke exposure 
  12 (13)  32 (16)  1.07 (0.49 to 2.33)  0.86     
Passive smoke exposure 
  19 (21)  25 (13)  2.34 (1.08, 5.04)  0.03     
No smoke exposure 
  45 (49)  123 (63)  1.00       
Diabetes mellitus 
Yes 
No 
28 (31) 
62 (69) 
32 (16) 
164 (84) 
2.33 (1.22 to 4.45)  0.01  2.27 (1.07 to 4.81)  0.03 
Hypertension 
Yes 
No 
47 (52) 
42 (47) 
86 (45) 
107 (55) 
1.61 (0.92 to 2.82)  .10     
Cardiac disease 
Yes 
No 
30 (33) 
60 (67) 
24 (12) 
172 (88) 
3.09 (1.58, 6.06)  0.001  3.24 (1.40 to 7.51)  0.006 
Chronic obstructive pulmonary disease (COPD) 
Yes 
No 
8 (9) 
79 (91) 
2 (1) 
193 (99) 
7.85 (1.50 to 41.07)  0.01     
Cancer 
Yes 
No 
18 (20) 
71 (80) 
22 (11) 
173 (89) 
2.58 (1.23 to 5.41)  .01  3.54 (1.44 to 8.70)  0.006 
Varicella 
Yes 
No 
1 (1) 
85 (99) 
0 
191 (100) 
Undefined  .99     
Cirrhosis 
Yes 
No 
5 (6) 
82 (94) 
0 
195 (100) 
Undefined  0.99     
Paralysis 
Yes 
No 
5 (6) 
84 (94) 
1 (1) 
195 (99) 
11.61 (1.34 to 100.87)  0.01     
Regular NSAID use 
Yes 
No 
43 (48) 
46 (52) 
64 (34) 
125 (66) 
1.82 (1.06 to 3.14)  0.03     
New use of NSAIDs 
Yes 
No 
14 (16) 
72 (84) 
14 (7) 
178 (93) 
2.13 (0.89 to 5.10)  0.09     
Use of corticosteroids 
Yes 
No 
9 (10) 
77 (90) 
3 (2) 
193 (98) 
4.96 (1.26 to 19.62)  0.02  5.18 (1.14, 23.54)  .03 
HIV+ 
Yes 
No 
1 (1) 
90 (99) 
2 (1) 
194 (99) 
.51 (0.04 to 6.14)  0.59     
Ever injected drugs 
Yes 
No 
6 (7) 
78 (93) 
3 (2) 
190 (98) 
5.48 (1.00 to 30.09)  0.05     
Alcohol use based on CAGE questions 
CAGE score 0 
CAGE score 1 
CAGE score 2 
CAGE score 3 
CAGE score 4 
42 (78) 
5 (9) 
2 (4) 
3 (6) 
2 (4) 
107 (77) 
19 (14) 
9 (6 ) 
4 (3) 
0 
0.95 (0.56 to 1.61)  .86     
aOR, odds ratio; CI, confidence interval; NSAID, nonsteroidal anti-inflammatory drug;  
bDue to missing data, for some variables, data for fewer than 91 case-patients and 196 control subjects were available. 
cAnalyses controlled for race and sex. ease. These conditions were not common among our study
participants; thus, the power of this investigation to identi-
fy them as significant risk factors was limited. Future
research into the association between invasive GAS dis-
ease and paralysis should include evaluation of the possi-
ble contribution of skin disruption. Varicella infection is a
well-documented risk factor in the development of inva-
sive GAS disease among children (1,9–14). 
We did not find an independent association between
invasive GAS and use of NSAIDs. The hypothesis that
NSAID use might increase the risk of necrotizing fasciitis
in children with varicella was first suggested by Brogan et
al. (11), and later observations by Peterson et al. supported
it (12). Several mechanisms by which NSAID use might
influence the incidence or severity of GAS infections have
been proposed (15). A recent prospective, multicenter
case-control study did not find that NSAID use increases
the risk of necrotizing GAS infections (16). Instead, their
data suggested that children with varicella were apt to take
NSAIDS because they were ill from varicella as opposed
to NSAIDS being a risk factor for later acquisition of inva-
sive GAS disease. 
A large proportion of the patients with invasive GAS
disease had a cutaneous form of the disease, and a large
portion of those with cutaneous disease reported an open
sore, bruise, or burn before the onset of invasive GAS
symptoms. This suggests the skin is an important portal of
entry for invasive GAS infection. 
Other studies have found an association between inva-
sive bacterial diseases and cigarette smoking (17,18). We
did not find this association. A true association may have
been undetectable because of the difficulty in ascertaining
smoking status over the telephone. 
Other studies have found an association between inva-
sive GAS disease and alcoholism (1). We did not find this
association. The sensitivity of the CAGE questions (7)
may be lower in phone interviews than in face-to-face
interviews. 
Our study found that environmental exposures were
important in the development of invasive GAS infection.
Specifically, we found that environmental exposures are
related to age. In younger adults, exposure to school-aged
children with a sore throat increased the risk of invasive
GAS disease. Household studies in the 1950s showed that
school-aged children are most likely to introduce group A
streptococcus into a household and that symptomatic chil-
dren are more efficient transmitters of infection than are
asymptomatic children (4). Surveillance in Toronto
demonstrated that the risk of colonization in the household
is associated with younger age and 4 or more hours of con-
tact with the infected person per day (1). More recently, the
role of transmission among household contacts has been
demonstrated in studies of community GAS outbreaks and
household contacts of patients with invasive GAS (19,20).
These studies suggest that infections among children may
represent an important reservoir for infections in adults.
This study has several limitations. The statistical power
of this study to detect the association between GAS infec-
tion and certain known risk factors, such as concomitant
varicella infection, was limited. Because we matched sub-
jects in terms of socioeconomic status, we were unable to
examine socioeconomic variables in our analysis. This
study included only people who have phones, and risk fac-
tors for invasive GAS disease may differ between people
who do not have phones and those who do. 
The results from this risk factor study can shape current
and future strategies to prevent invasive GAS disease.
Currently, these findings may help refine recommenda-
tions for prophylaxis of close contacts of persons with
invasive GAS disease. Vaccines for GAS disease are being
developed. Identifying those at greatest risk of invasive
GAS disease is important in developing vaccination rec-
ommendations. Our data suggest that vaccination should
be considered for those with history of injecting drug use,
HIV infection, diabetes mellitus, cardiac disease, cancer,
and use of corticosteroids. Our data also suggest that vac-
cination will provide benefits to those who receive the vac-
cine and to those with whom they live.  
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